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ABSTRACT
Febrile infection-related epilepsy syndrome is characterized by super refractory status epilepticus that is resistant to conventional antiepileptic drugs. 
This case report critically analyses the treatment options adopted in a hospital to manage this syndrome. Despite the aggressive efforts that were 
taken, the patient succumbed to the complications of the illness and side effects of the treatment strategies adopted. This shows that the treatment 
options currently available are in adequate, so an intensive research in the area of pathogenesis of status epilepticus is required to frame treatment 
strategies that can bring out better outcomes.
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INTRODUCTION
Febrile infection-related epilepsy syndrome (FIRES) is an acute onset 
epileptic encephalopathy in which previously healthy children present 
with prolonged treatment becomes resistant status epilepticus [1,2]. 
The clinical profile consists of an initial phase of febrile infection, 
followed by an acute phase marked by recurrent seizures (partial 
or secondary generalized seizures, facial myoclonus) during which 
the fever resolves. In the chronic phase survivors present with drug 
resistant epilepsy and neuropsychological impairment. Mortality rate 
in the acute phase is about 30%. Treatment requires polytherapy (on 
an average 6 antiepileptic drugs [AEDs] per patient). Early placement of 
patients on ketogenic diet might optimize seizure control and cognitive 
outcome after FIRES. The significant role of immunotherapy has not 
been proven [3,4].
CASE REPORT
A 11-year-old female child, with no significant history of neurological 
disorder, was admitted with case of status epilepticus following a period 
of febrile illness 3 weeks back. Shortly after the onset of fever she had 
developed abnormal behavior in the form of poor responsiveness and 
further developed seizures. Later the frequency of seizures increased 
and was admitted in the local hospital and evaluated. Magnetic 
resonance imaging (MRI) brain showed linear horizontal enhancing 
vessel extending from subependymal location of frontal horn suggestive 
of vascular malformation, venous angioma, occult cryptic vascular 
malformation with no evidence of obvious encephalitis or meningitis. 
Electroencephalography (EEG) showed bilateral temporo-occipital and 
temporal spikes. Other investigations done locally were shown in Table 1.
While at the local hospital she had multiple episodes of seizure. She was 
started on mannitol, antibiotics (tablet septran [sulfamethoxazole 400 
mg+trimethroprim 80 mg]), and antivirals (acyclovir 250 mg) there. A 
course of intravenous (IV) immunoglobulins (Ig) and steroids were also 
given. However she developed status epilepticus, she was ventilated 
and started on midazolam (10 mg/10 ml) infusion apart from AEDs 
(tablet eptoin 100 mg, phenobarbitone 60 mg, tablet phenytoin 100 mg, 
tablet levipil 100 mg, tablet clonazapam 1 mg, tablet lacosamide 50 mg, 
tablet frisium 5 mg, and tablet valparin 500 mg) and was referred to 
our hospital which is tertiary care referral center. On admission she 
was on ventilation, in view of recurrent seizures AEDs were optimized 
and titrated as per clinical requirement. MRI brain showed mild 
leptomeningeal enhancement especially involving bilateral superior 
fronto parietal. Antibiotics were started as per available culture 
sensitivity report. Supportive treatment in the form of blood product 
transfusion and electrolytes were given. In view of super refractory 
seizures, she was started on thiopentone infusion 1 g, injection 
fosphenytoin sodium 150 mg/2 ml, injection phenobarbitone 200 mg, 
tablet clonazepam 2 mg, injection levipil 500 mg/5 ml and which was 
gradually tapered. She was on multiple AEDs. She was given two cycles 
of plasmapheresis. Tracheostomy was done in view of need of prolonged 
ventilation. IV antibiotics (meropenem 500 mg, colistimethate sodium 
1,000,000 IU) were given as per c/s report. She was continued on AEDs 
and ketogenic diet. She was gradually weaned from bilevel positive 
airway pressure (BiPAP) but developed sudden asystole without prior 
desaturation or tachypnea and revived with resuscitative measures. 
Her ECHO done was normal. She developed bed sores for which plastic 
surgery consultation was taken. Debridement and exploration was 
done for the nonhealing bed sores. Later developed bleeding from 
debridement site and had altered coagulation parameters which were 
managed appropriately. In view of hypoalbuminemia and nonhealing 
ulcers her diet was changed from ketogenic diet to high protein diet. 
She had minor seizures during her hospital stay and EEG showed left 
parieto temporo-occipital epileptiform abnormalities. Follow-up EEG 
were done and her AEDs were stepped down. IV Albumin was given for 
3 days in view of hypoalbuminemia, 1 pint packed red blood cells was 
transfused in view of low Hb. Gradually her ventilator requirements 
were weaned down and BiPAP was started. Off BiPAP trials were 
given, but in view of tracheostomy leak, it was changed. Her serum 
phenobarbitone and eptoin levels were within normal limits. Nerve 
conduction velocity showed evidence for predominantly axonal type 
of sensory motor neuropathy affecting both lower limb more than 
upper limb and most probably suggestive of critical illness neuropathy. 
She was on antibiotics for bloodstream associated infection. Need for 
ventilation during BiPAP weaning trials has been explained in detail to 
her parents. Progress showed for few days. In spite of intensive care, 
she had a cardiorespiratory arrest and was not revived as per the 
wishes of family.
DISCUSSION
Children with FIRES get frequent focal seizures immediately after a 
febrile infection. These seizures develop rapidly to status epilepticus 
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which is pharmacoresistant and persist for several weeks to months. 
Survivors of acute phase progress into chronic phase results in 
pharmacoresistant status epilepticus and significant cognitive 
impairment [1,3-5]. The refractory seizures continue to occur despite 
treatment with multiple AEDs.
The largest, multicenter review in this area included 77 children. The 
acute mortality rate was 11.7% and 93% of the survivors had refractory 
status epilepticus. Only 18% of the survivors were cognitively normal. 
16% had borderline cognition, 14% had mild mental retardation, 
24% had moderate mental retardation and 12% had severe mental 
retardation, and 16% were in a vegetative state [4]. Death may occur in 
most refractory cases.
Therapy with benzodiazepines is given in early status epilepticus 
(IV midazolam/IV or rectal diazepam). IV antiepileptics are 
preferred in established status epilepticus. If seizures continue to 
persist for up to 2 hrs, despite the above treatment, then general 
anesthesia is recommended where dosing is based on EEG burst 
suppression approach (thiopental/pentobarbital/midazolam). This 
approach is associated with declining cognitive status. Anesthesia is 
recommended to prevent excitotoxicity. The disadvantage of anesthesia 
is hypotension, cardiorespiratory depression, and development of 
acute tolerance. Pentobarbital follows zero order kinetics, so it has a 
tendency to accumulate and prolong recovery phase [6,7]. Although 
the effectiveness of AEDs has not been clearly established in super 
refractory status epilepticus, it is a conventional practice to administer 
antiepileptics along with anesthesia. The AEDs conventionally used are 
carbamazepine, lacosamide, levetiracetam, phenobarbital, phenytoin, 
topiramate, and valproate. However, there is no evidence that any of 
these is less or more effective than other [8]. The recognition that super 
refractory status epilepticus may be due to antibodies directed against 
neural elements and that inflammation plays an important role in 
epileptogenesis have led to potential use of steroid and immunotherapy. 
However there are no clear guidelines about dose, duration of 
therapy, and evaluation of effectiveness. Steroids are associated with 
gastrointestinal ulceration, sodium and fluid retention, and psychiatric 
disturbances. Major adverse effects of Ig are coagulation disorders and 
hypertension [9-11]. Early ketogenic diet treatment, especially during 
acute phase, may optimize both seizure control and cognitive outcomes 
in FIRES [4]. Ketogenic diet is associated with acidosis, constipation, 
hypoglycemia, and hypercholesterolemia. The successful use of 
magnesium infusion and hypothermia in status epilepticus has also 
been reported [12,13].
CONCLUSION
The etiology of FIRES has not been clearly defined. Optimum seizure 
control is not obtained using conventional multiple AEDs. Clear 
knowledge about the underlying pathophysiology is required to frame 
treatment strategies. Several hypotheses have been put forward and the 
scope for future research in this area is huge. A child with refractory 
seizures requires the care of a highly skilled team with expertise in 
pediatric intensive care, neurology, epileptology, nursing, pharmacy, 
and dietitian.
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Dengue (IgM antibody) Negative
CSF: Cerebrospinal fluid, HSV-PCR: Herpes simplex virus-polymerase chain 
reaction, ANA: Antinuclear antibodies, IgM: Immunoglobulins M
